{"entity":{"type":"insider","cik":"0001842369","url":"/insider/0001842369","json_url":"/insider/0001842369.json","name":"Luu Brendan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2023-12-06","last":"2025-12-05","span_basis":"filed_date"},"name_variants":[{"name":"Luu Brendan","source":"filing","n_filings":3,"first_seen":"2023-12-06","last_seen":"2025-12-05"}],"transactions":[{"id":4079045,"accession":"0002064832-25-000063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002064832-25-000063","line_url":"/filing/0002064832-25-000063#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001842369","owner_name":"Luu Brendan","owner_display_name":"Luu Brendan","owner_url":"/insider/0001842369","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1394.0,"shares_display":"1,394","price_per_share":14.23,"price_display":"14.23","price_state":"stated","total_value":19836.62,"total_display":"19,836.62","total_whole":"19,837","shares_owned_after":38329.0,"shares_owned_after_display":"38,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider"},{"id":2777155,"accession":"0001062993-24-020384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-020384","line_url":"/filing/0001062993-24-020384#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001842369","owner_name":"Luu Brendan","owner_display_name":"Luu Brendan","owner_url":"/insider/0001842369","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2283.0,"shares_display":"2,283","price_per_share":8.06,"price_display":"8.06","price_state":"stated","total_value":18400.98,"total_display":"18,400.98","total_whole":"18,401","shares_owned_after":36047.0,"shares_owned_after_display":"36,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":8647943,"accession":"0001062993-23-022057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-022057","line_url":"/filing/0001062993-23-022057#line-1","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001842369","owner_name":"Luu Brendan","owner_display_name":"Luu Brendan","owner_url":"/insider/0001842369","role":"Officer (Sr. VP, Business Dev)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Business Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Business Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2125.0,"shares_display":"2,125","price_per_share":9.63,"price_display":"9.63","price_state":"stated","total_value":20463.75,"total_display":"20,463.75","total_whole":"20,464","shares_owned_after":36736.0,"shares_owned_after_display":"36,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Officer (Chief Business Officer)","n_filings":3,"first_seen":"2023-12-06","last_seen":"2025-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001842369","retrieved_at":"2026-08-25T18:07:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}